Dosimetric benefit to organs at risk following margin reductions in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy

Yan-Ping Mao, Wen-Jing Yin, Rui Guo, Guang-Shun Zhang, Jian-Lan Fang, Feng Chi, Zhen-Yu Qi, Meng-Zhong Liu, Jun Ma, Ying Sun, Yan-Ping Mao, Wen-Jing Yin, Rui Guo, Guang-Shun Zhang, Jian-Lan Fang, Feng Chi, Zhen-Yu Qi, Meng-Zhong Liu, Jun Ma, Ying Sun

Abstract

Introduction: It is important to decrease the radiation exposure of normal tissue in intensity-modulated radiation therapy (IMRT). Minimizing planning target volume (PTV) margins with more precise target localization techniques can achieve this goal. This study aimed to quantify the extent to which organs at risk (OARs) are spared when using reduced margins in the treatment of nasopharyngeal carcinoma (NPC).

Methods: Two IMRT plans were regenerated for 40 patients with NPC based on two PTV margins, which were reduced or unchanged following cone beam computed tomography online correction. The reduced-margin plan was optimized based on maximal dose reduction to OARs without compromising target coverage. Dosimetric comparisons were evaluated in terms of target coverage and OAR sparing.

Results: Improvements in target coverage occurred with margin reduction, and significant improvements in dosimetric parameters were observed for all OARs (P < 0.05) except for the right optic nerve, chiasm, and lens. Doses to OARs decreased at a rate of 1.5% to 7.7%. Sparing of the left parotid and right parotid, where the mean dose (Dmean) decreased at a rate of 7.1% and 7.7%, respectively, was greater than the sparing of other OARs.

Conclusions: Significant improvements in OAR sparing were observed with margin reduction, in addition to improvement in target coverage. The parotids benefited most from the online imaging-guided approach.

Figures

Figure 1
Figure 1
Average dose volume histograms of plans with pre-correction margins and plans with post-correction margins for all 40 patients with nasopharyngeal carcinoma. Each picture is based on the average dose volume histogram to an organ at risk. L, left; R, right; TM, temporomandibular.

References

    1. Chan AT, Teo PM, Johnson PJ. Nasopharyngeal carcinoma. Ann Oncol. 2002;13:1007–15. doi: 10.1093/annonc/mdf179.
    1. Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60:1440–50. doi: 10.1016/j.ijrobp.2004.05.022.
    1. Lin S, Pan J, Han L, Zhang X, Liao X, Lu JJ. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys. 2009;75:1071–8. doi: 10.1016/j.ijrobp.2008.12.015.
    1. Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol. 2007;25:4873–9. doi: 10.1200/JCO.2007.11.5501.
    1. Petsuksiri J, Sermsree A, Thephamongkhol K, Keskool P, Thongyai K, Chansilpa Y, et al. Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients. Radiat Oncol. 2011;6:19. doi: 10.1186/1748-717X-6-19.
    1. Hanley J, Debois MM, Mah D, Mageras GS, Raben A, Rosenzweig K, et al. Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. Int J Radiat Oncol Biol Phys. 1999;45:603–11. doi: 10.1016/S0360-3016(99)00154-6.
    1. Grills IS, Hugo G, Kestin LL, Galerani AP, Chao KK, Wloch J, et al. Image-guided radiotherapy via daily online cone-beam CT substantially reduces margin requirements for stereotactic lung radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70:1045–56. doi: 10.1016/j.ijrobp.2007.07.2352.
    1. Song S, Yenice KM, Kopec M, Liauw SL. Image-guided radiotherapy using surgical clips as fiducial markers after prostatectomy: a report of total setup error, required PTV expansion, and dosimetric implications. Radiother Oncol. 2012;103:270–4. doi: 10.1016/j.radonc.2011.07.024.
    1. Stutzel J, Oelfke U, Nill S. A quantitative image quality comparison of four different image guided radiotherapy devices. Radiother Oncol. 2008;86:20–4. doi: 10.1016/j.radonc.2007.10.035.
    1. Korreman S, Rasch C, McNair H, Verellen D, Oelfke U, Maingon P, et al. The European Society of Therapeutic Radiology and Oncology–European Institute of Radiotherapy (ESTRO–EIR) report on 3D CT-based in-room image guidance systems: a practical and technical review and guide. Radiother Oncol. 2010;94:129–44. doi: 10.1016/j.radonc.2010.01.004.
    1. Den RB, Doemer A, Kubicek G, Bednarz G, Galvin JM, Keane WM, et al. Daily image guidance with cone-beam computed tomography for head-and neck cancer intensity-modulated radiotherapy: a prospective study. Int J Radiat Oncol Biol Phys. 2010;76:1353–9. doi: 10.1016/j.ijrobp.2009.03.059.
    1. Wang J, Bai S, Chen N, Xu F, Jiang X, Li Y, et al. The clinical feasibility and effect of online cone beam computer tomography-guided intensity-modulated radiotherapy for nasopharyngeal cancer. Radiother Oncol. 2009;90:221–7. doi: 10.1016/j.radonc.2008.08.017.
    1. van Herk M, Remeijer P, Rasch C, Lebesque JV. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47:1121–35. doi: 10.1016/S0360-3016(00)00518-6.
    1. Burrows J. Use of Monte Carlo simulations in the assessment of calibration strategies–Part I: an introduction to Monte Carlo mathematics. Bioanalysis. 2013;5:935–43. doi: 10.4155/bio.13.32.
    1. Velec M, Waldron JN, O’Sullivan B, Bayley A, Cummings B, Kim JJ, et al. Cone-beam CT assessment of interfraction and intrafraction setup error of two head-and-neck cancer thermoplastic masks. Int J Radiat Oncol Biol Phys. 2010;76:949–55. doi: 10.1016/j.ijrobp.2009.07.004.
    1. Zeidan OA, Langen KM, Meeks SL, Manon RR, Wagner TH, Willoughby TR, et al. Evalution of image-guidance protocols in the treatment of head and neck cancers. Int J Radiat Oncol Biol Phys. 2007;67:670–7. doi: 10.1016/j.ijrobp.2006.09.040.
    1. Litzenberg DW, Balter JM, Lam KL, Sandler HM, Ten Haken RK. Retrospective analysis of prostate cancer patients with implanted gold markers using off-line and adaptive therapy protocols. Int J Radiat Oncol Biol Phys. 2005;63:123–33. doi: 10.1016/j.ijrobp.2005.02.013.
    1. van Asselen B, Dehnad H, Raaijmakers CP, Roesink JM, Lagendijk JJ, Terhaard CH. The dose to the parotid glands with IMRT for oropharyngeal tumor: the effect of reduction of positioning margins. Radiother Oncol. 2002;64:197–204. doi: 10.1016/S0167-8140(02)00152-4.
    1. Sun Y, Yu XL, Luo W, Lee AW, Wee JT, Lee N, et al. Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy. Radiother Oncol. 2014;110:390–7. doi: 10.1016/j.radonc.2013.10.035.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel